Matthew C Findlay, Mohammadmadhi Sabahi, Mohammed Azab, Richard Drexler, Roman Rotermund, Franz L Ricklefs, Jörg Flitsch, Timothy R Smith, John L Kilgallon, Jürgen Honegger, Isabella Nasi-Kordhishti, Paul A Gardner, Zachary C Gersey, Hussein M Abdallah, John A Jane, Ulrich J Knappe, Nesrin Uksul, Henry W S Schroder, Márton Eördögh, Marco Losa, Pietro Mortini, Rüdiger Gerlach, Apio C M Antunes, William T Couldwell, Karol P Budohoski, Robert C Rennert, Michael Karsy
OBJECTIVE: First-line prolactin-secreting tumor (PST) management typically involves treatment with dopamine agonists and the role of surgery remains to be further explored. We examined the international experience of 12 neurosurgical centers to assess the patient characteristics, safety profile, and effectiveness of surgery for PST management. METHODS: Patients surgically treated for PST from January 2017 through December 2020 were evaluated for surgical characteristics, outcomes, and safety...
December 10, 2023: Clinical Neurology and Neurosurgery